Suchergebnisse

PubPharm (26)

1

Natural infection by Zika virus but not DNA vaccination consistently elicits antibodies that compete with two potently neutralising monoclonal antibodies targeting distinct epitopes

enthalten in: EBioMedicine | 2023

von Smith, T. | Espinoza, D. | Zhu, Y. | +11

2

Incidence of Cytomegalovirus Primary and Secondary Infection in Adolescent Girls : Results From a Prospective Study

enthalten in: The Journal of infectious diseases | 2023

von Paris, R. | Apter, D. | Boppana, S. | +10

3

Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity

enthalten in: Nature communications | 2023

von Altmann, D. | Reynolds, C. | Joy, G. | +14

4

Sustained and Boosted Antibody Responses in Breast Milk After Maternal SARS-CoV-2 Vaccination

enthalten in: Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine | 2023

von Ware, J. | McElhinney, K. | Latham, T. | +5

5

Comparison of the prevalence of SARS-CoV-2 nucleoprotein antibodies in healthcare workers and an unselected adult and paediatric all-comer patient population : insights from a longitudinal study of healthcare workers and concurrent serial cross-sectional studies of patients at an academic medical centre in Austria

enthalten in: BMJ open | 2023

von Riesenhuber, M. | Nitsche, C. | Binder, C. | +9

6

Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis : Immunogenicity, safety, antibody decay and the booster dose

enthalten in: Clinics (Sao Paulo, Brazil) | 2023

von Pereira, R. | Dagostin, M. | Caparbo, V. | +14

7

Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA.1 infection

enthalten in: Emerging microbes & infections | 2022

von Kurhade, C. | Zou, J. | Xia, H. | +11

8

SARS-CoV-2 humoral responses following booster BNT162b2 vaccination in patients with B-cell malignancies

enthalten in: American journal of hematology | 2022

von Terpos, E. | Fotiou, D. | Karalis, V. | +8

9

Decreased Efficiency of Neutralizing Antibodies from Previously Infected or Vaccinated Individuals against the B.1.617.2 (Delta) SARS-CoV-2 Variant

enthalten in: Microbiology spectrum | 2022

von Dimeglio, C. | Herin, F. | Da-Silva, I. | +4

10

Efficacy and safety of mRNA SARS-CoV-2 vaccines in lung transplant recipients

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2022

von Hirama, T. | Akiba, M. | Shundo, Y. | +5